About this trial
Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Black women
between 18-25 years of age
BMI ≥ 25 kg/m²
At least one binge eating episode weekly
Disqualifiers
Have no internet access
Currently type 2 diabetic
Currently pregnant
Are in substance use treatment
Trial design
Parallel
Treatments tested in this trial
Appetite Awareness Training (AAT)
BehavioralPartcipants will receive the AAT delivered as 16 core sessions over six months as well as six maintenance sessions over the course of 12 months.
Diabetes Prevention Program (DPP)
BehavioralPartcipants will receive the DPP delivered as 16 core sessions over six months as well as six maintenance sessions over the course of 12 months.
Treatment groups
Trial outcomes
Primary outcomes
Change in number of Binge Eating Episodes from Baseline to Month 6
Participants will self-monitor and complete surveys on binge eating episodes.
Change from Baseline to Month 6 in weight regain
Participant body weight will be measured by trained research staff using calibrated digital scales. Participants will be in light indoor clothing, with pockets emptied, and belts and shoes removed.
Secondary outcomes
Change in Inflammatory Biomarkers for T2DM from Baseline to Month 6
Participants will provide plasma samples to examine the risk for type 2 diabetes mellitus.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of North Carolina, Chapel Hill
Lead sponsor
American Diabetes Association
Collaborator